C07K 14/445
Plasmodium
C07K14/445 (Plasmodium) appears on 432 US grants and 447 published applications in this corpus.
Search patents in C07K- Granted patents
- 432
- Published applications
- 447
- Assignees
- 286
- Inventors
- 1,025
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 7 | 0 |
| 1990 | 7 | 0 |
| 1991 | 9 | 0 |
| 1992 | 13 | 0 |
| 1993 | 17 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 13 | 0 |
| 1997 | 18 | 0 |
| 1998 | 18 | 0 |
| 1999 | 13 | 0 |
| 2000 | 15 | 0 |
| 2001 | 11 | 0 |
| 2002 | 11 | 23 |
| 2003 | 12 | 44 |
| 2004 | 13 | 36 |
| 2005 | 13 | 23 |
| 2006 | 12 | 17 |
| 2007 | 9 | 18 |
| 2008 | 13 | 16 |
| 2009 | 13 | 20 |
| 2010 | 12 | 34 |
| 2011 | 14 | 18 |
| 2012 | 16 | 19 |
| 2013 | 8 | 14 |
| 2014 | 12 | 13 |
| 2015 | 12 | 17 |
| 2016 | 10 | 21 |
| 2017 | 20 | 17 |
| 2018 | 10 | 12 |
| 2019 | 13 | 15 |
| 2020 | 11 | 12 |
| 2021 | 9 | 16 |
| 2022 | 9 | 8 |
| 2023 | 6 | 7 |
| 2024 | 6 | 10 |
| 2025 | 8 | 9 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host13 Jan 2026US 12,521,428 B2Institut Pasteur
- Synthetic plasmodium antigens, compositions, and uses thereof2 Sep 2025US 12,404,311 B2Case Western Reserve University
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof26 Aug 2025US 12,398,184 B2University of South Florida
- Amino acid-specific binder and selectively identifying an amino acid15 Apr 2025US 12,275,760 B2Government of the United States of America, AS Represented By the Secretary of Commerce
- System, method, apparatus and diagnostic test for plasmodium vivax25 Mar 2025US 12,259,387 B2The Walter and Eliza Hall Institute of Medical Research
- Optimized csp variants and related methods8 Oct 2026US 2026/0308209 A1
- Compositions for delivery of liver stage antigens and related methods3 Sep 2026US 2026/0256898 A1BioNTech SE
- Vaccine6 Aug 2026US 2026/0224681 A1Oxford University Innovation Limited
- Stabilized pfs48/45 proteins and uses thereof23 Jul 2026US 2026/0207725 A1The United States of America, as represented by the Secretary, Department of Health and Human
- Recombinant var2csa protein, and preparation method and use thereof16 Jul 2026US 2026/0200996 A1Sun Yat-sen University Cancer Center (The Affiliated Cancer Hospital of Sun Yat-sen University, The
Most cited
By later US patents
- Multiple antigen peptide system261US 5,229,490 AThe Rockefeller University · 1993
- Vaccinia DNA172US 5,017,487 AHoffmann-La Roche Inc. · 1991
- Synthetic ligation reassembly in directed evolution148US 6,537,776 B1Diversa Corporation · 2003
- Saturation mutagenesis in directed evolution147US 6,171,820 B2Diversa Corporation · 2001
- Recombinant MVA vaccinia virus120US 5,185,146 AHoffmann-LaRoche Inc. · 1993